| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Department of Medicine and Therapeutics (J.R.P., K.M., H.L.E., J.McC.), West Glasgow Hospitals University NHS Trust, University of Glasgow, Glasgow G11 6NT; Department of Medicine (A.D.M.), Ninewells Hospital and Medical School, University of Dundee, Dundee 001954; Department of Clinical Physics and Bio-Engineering (T.E.H.), West Glasgow Hospitals University National Health Service Trust, Glasgow G11 6NT; Diabetes Centre (M.S.), West Glasgow Hospitals University NHS Trust, Glasgow G120YN, United Kingdom
Address all correspondence and requests for reprints to: Dr. John R. Petrie, Department of Medicine and Therapeutics, Western Infirmary, Glasgow G11 6NT, United Kingdom. E-mail: jrp1s{at}clinmed.gla.ac.uk
Dietary sodium restriction has a variety of effects on metabolism, including activation of the renin-angiotensin system. Angiotensin II has complex metabolic and cardiovascular effects, and these may be relevant to the effects of both nonpharmacological and pharmacological interventions in noninsulin-dependent diabetes mellitus (NIDDM). We have assessed the effect of dietary sodium restriction on insulin sensitivity and endogenous glucose production in eight normotensive patients with diet-controlled NIDDM who underwent hyperinsulinemic clamp studies in a randomized, double-blind, placebo-controlled cross-over protocol after two 4-day periods on sodium replete (160 mmol/day) and sodium deplete (40 mmol/day) diets. Mean ± SD 24-h urinary sodium was 197 ± 76.0 mmol (replete) and 67 ± 19.5 mmol (deplete), P = 0.03. Insulin sensitivity was 42.0 ± 11.3 µmol/kg·min (replete) and 37.0 ± 11.6 µmol/kg·min (deplete), P = 0.04 (a reduction of 12%). Blood pressure was 130 ± 21/78 ± 11 mmHg (replete) and 128 ± 12/73 ± 10 mmHg (deplete). Dietary sodium restriction may result in a decrease in peripheral insulin sensitivity in normotensive patients with NIDDM, possibly via an elevation in prevailing angiotensin II concentrations.
This article has been cited by other articles:
![]() |
M. H. Alderman Evidence relating dietary sodium to cardiovascular disease. J. Am. Coll. Nutr., June 1, 2006; 25(3 Suppl): 256S - 261S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H Alderman Salt, blood pressure and health: a cautionary tale Int. J. Epidemiol., April 1, 2002; 31(2): 311 - 316. [Full Text] [PDF] |
||||
![]() |
A. C. Duncan, H. Lyall, R.N. Roberts, J. R. Petrie, M. J. Perera, S. Monaghan, D. M. Hart, J. M. C. Connell, and M. A. Lumsden The Effect of Estradiol and a Combined Estradiol/Progestagen Preparation on Insulin Sensitivity in Healthy Postmenopausal Women J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2402 - 2407. [Abstract] [Full Text] |
||||
![]() |
F. S. Facchini, C. DoNascimento, G. M. Reaven, J. W. Yip, X. P. Ni, and M. H. Humphreys Blood Pressure, Sodium Intake, Insulin Resistance, and Urinary Nitrate Excretion Hypertension, April 1, 1999; 33(4): 1008 - 1012. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |